4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-069036
Chief Scientific Officer acquired 20,562 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fisher Stewart Chief Scientific Officer | 2021-12-08 | Option exercise | +2,373 | $2.11 | $5,007 | 25,117 | D |
| Fisher Stewart Chief Scientific Officer | 2021-12-08 | Option exercise | +17,786 | $3.71 | $65,986 | 42,903 | D |
| Fisher Stewart Chief Scientific Officer | 2021-12-08 | Option exercise | +403 | $4.98 | $2,007 | 43,306 | D |
| Derivatives | |||||||
| Fisher Stewart Chief Scientific Officer | 2021-12-08 | Option exercise · Stock Option (Right to Buy) | −2,373 | 0 | D | ||
| Fisher Stewart Chief Scientific Officer | 2021-12-08 | Option exercise · Stock Option (Right to Buy) | −17,786 | 37,728 | D | ||
| Fisher Stewart Chief Scientific Officer | 2021-12-08 | Option exercise · Stock Option (Right to Buy) | −403 | 203,994 | D | ||
Loading xslF345X03/doc4.xml…